Case Type: Mergers & Acquisitions

Boundless Bio, Inc. (NASDAQ: BOLD) related to its merger with Serapha Bio, Inc. Upon closing of the proposed transaction, Boundless Bio shareholders are expected to own approximately 3.7% of the combined company.

Apogee Therapeutics, Inc. (NASDAQ: APGE) related to its sale to AbbVie Inc. Under the terms of the proposed transaction, Apogee shareholders are expected to receive $135.11 per share in cash.

Arcosa, Inc. (NYSE: ACA) related to its sale to CRH Americas, Inc. Under the terms of the proposed transaction, Arcosa shareholders are expected to receive $150.00 per share in cash.

Simulations Plus, Inc. (NASDAQ: SLP) related to its sale to affiliates of Altaris, LLC. Under the terms of the proposed transaction, Simulations Plus shareholders are expected to receive $18.50 per share in cash.

Bio Green Med Solution, Inc. (NASDAQ: BGMS) related to its merger with Future NRG Sdn. Bhd.

AstroNova, Inc. (NASDAQ: ALOT) related to its sale to Arcline Investment Management. Under the terms of the proposed transaction, AstroNova shareholders are expected to receive $29.00 per share in cash.

Fathom Holdings Inc. (NASDAQ: FTHM) related to its sale to Bed Bath & Beyond, Inc. Under the terms of the proposed transaction, Fathom shareholders will receive 0.2236 shares of Bed Bath & Beyond common stock for each Fathom share.

Olin Corporation (NYSE: OLN) related to its merger with Huntsman Corporation. Upon closing of the proposed transaction, Olin shareholders will own approximately 54.5% of the combined company.

Huntsman Corporation (NYSE: HUN) related to its sale to Olin Corporation. Under the terms of the proposed transaction, Huntsman shareholders are expected to receive 0.5476 shares of Olin for each share of Huntsman.

Open Lending Corporation (NASDAQ: LPRO) related to its sale to ANV Group Holdings Ltd. Under the terms of the proposed transaction, Open Lending shareholders are expected to receive $3.15 per share in cash.